NCT05911295
Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2 treatment 3 recruiting NCT06034860
Study of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer Types treatment 1 active_not_recruiting NCT06047379
Safety and Efficacy of NEO212 in Patients with Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis treatment 1 / 2 recruiting NCT06310759
Prospective Validation Study of High Volume Urine DNA Testing in Individuals with Suspicion of Urothelial Cancer No drug interventions Not Available Not Available recruiting NCT06617169
Dose-Escalation of MNPR-101-PCTA-177Lu in Solid Tumors treatment 1 recruiting NCT03473743
A Study of Erdafitinib in Participants With Metastatic or Locally Advanced Urothelial Cancer treatment 1 / 2 active_not_recruiting NCT06632262
A Phase 2 Clinical Study of ABSK061 and ABSK043 No drug interventions treatment 2 not_yet_recruiting NCT06632951
Study to Evaluate Adverse Events and Change in Disease Activity When Intravenously (IV) Infused Livmoniplimab is Used in Combination With IV Infused Budigalimab in Adult Participants With Urothelial Carcinoma (UC) treatment 2 not_yet_recruiting NCT05581004
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors treatment 1 recruiting NCT06171789
PRO1107 in Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT02769962
Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer treatment 1 / 2 recruiting NCT04242199
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT04822350
A NON-INTERVENTIONAL STUDY ON AVELUMAB USE IN PATIENTS WITH ADVANCED OR METASTATIC UROTHELIAL CARCINOMA Not Available Not Available active_not_recruiting NCT05544552
Safety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors With FGFR3 Gene Alterations No drug interventions treatment 1 / 2 recruiting NCT05661955
A Study to Investigate the Antitumor Activity, Safety, Tolerability, and Pharmacokinetics of BGB-A445 in Combination With Tislelizumab in Participants With Select Advanced Solid Tumors. treatment 1 / 2 recruiting NCT04879329
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2 treatment 2 recruiting NCT04895709
A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors treatment 1 / 2 recruiting NCT05078047
Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO No drug interventions treatment 3 recruiting NCT05136898
Feasibility of Home Instillation of UGN-102 for Treatment of Low-Grade (LG) Non-Muscle Invasive Bladder Cancer (NMIBC) treatment 3 completed NCT05406713
Pembrolizumab in Muscle-invasive Bladder Cancer treatment 2 recruiting NCT05620134
Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer treatment 1 / 2 recruiting NCT05714553
NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours treatment 1 / 2 recruiting NCT06318871
Memory-like Natural Killer (NK) Cell Therapy in Patients with Renal Cell Carcinoma or Urothelial Carcinoma treatment 0 recruiting NCT06331299
A Phase 3 Study of UGN-103 for Treatment of Patients With Low-grade Intermediate-risk Non-muscle Invasive Bladder Cancer treatment 3 recruiting NCT06332755
Study to Evaluate LB-LR1109 for the Treatment of Solid Tumors No drug interventions treatment 1 recruiting NCT06337084
Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients with Solid Tumors No drug interventions diagnostic 1 recruiting NCT06412848
JAVEMACS: Japan AVElumab Maintenance And Continuous Treatment Study Not Available Not Available completed NCT06424717
Study of Avelumab and Tuvusertib in Participants With Advanced Urothelial Cancer That Has Progressed on Prior Anti-PD-(L)1 Therapy (JAVELIN DDRiver Bladder) treatment 2 withdrawn NCT06592326
9MW2821 in Combination With Toripalimab vs Standard Chemotherapy in Locally Advanced or Metastatic Urothelial Cancer treatment 3 recruiting NCT03558503
A Phase 2b Study of UGN-102 for Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer treatment 2 completed NCT05867303
A RC198 Study in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT03869190
Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatments and Combinations in Patients With Urothelial Carcinoma (MORPHEUS-UC) treatment 1 / 2 recruiting NCT06101290
Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER) No drug interventions treatment Not Available recruiting NCT00854464
Arsenic Methylation Enzymes, Cigarette Metabolites, DNA Repair Enzymes, Inflammatory Factors and Urothelial Carcinoma No drug interventions Not Available Not Available unknown_status NCT02500121
Testing the PD-1 Inhibitor Pembrolizumab as Maintenance Therapy After Initial Chemotherapy in Metastatic Bladder Cancer treatment 2 completed NCT04535921
Fear of Cancer Recurrence in Genitourinary Cancer No drug interventions Not Available Not Available completed NCT03794102
Water Versus Saline as Irrigation Fluid for Ureteroscopy No drug interventions other Not Available completed NCT04601402
GEN-001 (Live Biotherapeutic Product) and Avelumab Combination Study for Patients With Solid Tumors Who Have Progressed on Anti-PD-(L)1 Therapy treatment 1 completed NCT04260802
A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers treatment 1 / 2 recruiting NCT02989584
A Phase II Study of Atezolizumab in Combination With Cisplatin + Gemcitabine Before Surgery to Remove the Bladder Cancer treatment 1 / 2 active_not_recruiting NCT03179943
Atezolizumab + Guadecitabine in Patients With Checkpoint Inhibitor Refractory or Resistant Urothelial Carcinoma treatment 2 active_not_recruiting NCT04322643
Intermittent Checkpoint Inhibitor Therapy In Patients With Advanced Urothelial Carcinoma treatment 2 completed NCT06396533
Increasing Pre-Surgical Identification of Muscle Invasive Tumor Evaluations Prior to Planned Cystectomy (INSITE) No drug interventions Not Available Not Available active_not_recruiting NCT06218433
Urothelial Cancer Screening in Individuals With Lynch Syndrome Using a Urine Tumor DNA Panel (LS-URO Study) No drug interventions screening Not Available recruiting NCT00867633
Aristolochic Acid-DNA Adduct in Urothelial Carcinoma in Taiwan No drug interventions Not Available Not Available unknown_status NCT04018053
18Fluorine-Fluciclovine PET/CT for Staging Muscle Invasive Bladder Cancer Preceding Radical Cystectomy diagnostic 0 active_not_recruiting NCT03652077
A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies treatment 1 completed NCT05030077
Anlotinib Combined With Platinum/Gemcitabine for First Line Treatment of Advanced Urothelial Carcinoma treatment 2 unknown_status NCT05861947
A Phase 1 Clinical Trial of AUR106 in Patients With Relapsed Advanced Malignancies No drug interventions treatment 1 recruiting NCT01844947
Phase I Study With Sorafenib in Addition to Vinflunine in Metastatic Transitional Cell Carcinoma of the Urothelial Tract treatment 1 completed NCT05894447
Naptumomab Estafenatox in Combination With Pembrolizumab Preceded by Obinutuzumab in Patients With Urothelial Cancers treatment 1 withdrawn NCT02983045
A Dose Escalation and Cohort Expansion Study of NKTR-214 in Combination With Nivolumab and Other Anti-Cancer Therapies in Patients With Select Advanced Solid Tumors treatment 1 / 2 completed NCT01780545
Phase 2 Study of Docetaxel +/- OGX-427 in Patients With Relapsed or Refractory Metastatic Bladder Cancer treatment 2 completed NCT01606345
Phase I Study of Percutaneous Valrubicin for Upper Tract Urothelial Carcinoma treatment 1 completed NCT05912205
Disitamab Vedotin Combined With Radiotherapy for Bladder Preservation treatment 2 not_yet_recruiting NCT03486197
Neutron Radiation Therapy and Pembrolizumab in Treating Participants With Advanced Urothelial Carcinoma treatment 2 terminated NCT06451497
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors No drug interventions other 1 recruiting NCT06138561
Management of Cisplatin-Ineligible Patients With Metastatic Bladder Cancer and The Role of Geriatric Assessments No drug interventions Not Available Not Available recruiting NCT03387761
Neo-Adjuvant Bladder Urothelial Carcinoma COmbination-immunotherapy treatment 1 completed NCT01071928
Second-Line Docetaxel + ASA404 for Advanced Urothelial Carcinoma treatment 2 withdrawn NCT03538028
A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies treatment 1 completed NCT06421311
Observational Study of Muscle Invasive Urothelial Carcinoma Participants Treated With Adjuvant Nivolumab in France Not Available Not Available recruiting NCT03171493
Trial of Intravesical Measles Virotherapy in Patients With Bladder Cancer Who Are Undergoing Radical Cystectomy No drug interventions treatment 1 completed NCT03197571
QUILT-3.048: NANT Urothelial Cancer Vaccine: Combination Immunotherapy in Subjects With Urothelial Cancer Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy treatment 1 / 2 withdrawn NCT05219578
RTX-224 Monotherapy in Patients With Solid Tumors No drug interventions treatment 1 / 2 terminated NCT02479178
A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck treatment 2 terminated NCT06438588
Fasting Mimicking Diet for Reducing Immune Related Adverse Events for Cancer Patients on Immune Checkpoint Inhibitors, FMD-ICI Trial No drug interventions supportive_care Not Available recruiting NCT04666688
LYT-200 Alone and in Combination With Chemotherapy or Tislelizumab in Patients With Locally Advanced or Metastatic Solid Tumors treatment 1 / 2 recruiting NCT01437488
Cabazitaxel in Patients With Urothelial Carcinoma Who Have Disease Progression Following Platinum-Based Chemotherapy treatment 2 completed NCT04432909
A Prospective, Multi-centre, Single-blinded Study of UroCAD for Urothelial Carcinoma Diagnosis and Follow-up No drug interventions Not Available Not Available unknown_status NCT03636256
Evaluation of NanoDoce® in Participants With Urothelial Carcinoma treatment 1 / 2 completed NCT02795156
Study Assessing Activity of Molecularly Matched Targeted Therapies in Select Tumor Types Based on Genomic Alterations treatment 2 completed NCT04617756
Safety & Efficacy of Durvalumab+Neoadjuvant Chemotherapy for High-risk Urothelial Carcinoma of the Upper Urinary Tract treatment 2 recruiting NCT03473756
Phase 1b/2 Study of Rogaratinib (BAY1163877) in Combination With Atezolizumab in Urothelial Carcinoma treatment 1 active_not_recruiting NCT03665285
A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors No drug interventions treatment 1 / 2 completed NCT03502785
INO-5401 + INO-9012 in Combination With Atezolizumab in Locally Advanced Unresectable or Metastatic/Recurrent Urothelial Carcinoma treatment 1 / 2 active_not_recruiting NCT01490437
Pemetrexed and Cisplatin in Advanced Urothelial Carcinoma treatment 2 completed NCT05098132
Phase 1a/1b Study of STK-012 Monotherapy and in Combination With Pembrolizumab in Patients With Solid Tumors treatment 1 recruiting NCT04244552
A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies treatment 1 terminated NCT02573259
A Dose Escalation Study Of PF-06801591 In Melanoma, Head And Neck Cancer (SCCHN), Ovarian, Sarcoma, Non-Small Cell Lung Cancer, Urothelial Carcinoma or Other Solid Tumors No drug interventions treatment 1 completed NCT03062059
The Effectiveness and Safety of Intravesical Gemcitabine Instillation to Prevent Intravesical Recurrence prevention 2 unknown_status NCT03280459
Evaluation of Robot-assisted Intracorporeal Urinary Reconstruction No drug interventions Not Available Not Available unknown_status NCT04077359
Prospective Trial for Examining Hematuria Using Computed Tomography No drug interventions diagnostic Not Available completed NCT04565275
A Study of ICP-192 in Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT04004442
Avelumab in Combination With AVB-S6-500 in Patients With Advanced Urothelial Carcinoma treatment 1 active_not_recruiting NCT04060342
GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma treatment 1 terminated NCT05520099
Observational Basket Trial to Collect Tissue to Train and Validate a Live Tumor Diagnostic Platform No drug interventions Not Available Not Available recruiting NCT01688999
Cabozantinib for Advanced Urothelial Cancer treatment 2 completed NCT04152499
Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies treatment 1 / 2 recruiting NCT05234606
A Safety and Preliminary Efficacy Study of SBT6290 Alone and in Combination With PD-(L)1 Inhibitors in Select Advanced Solid Tumors treatment 1 / 2 withdrawn NCT03871036
Improve Checkpoint-blockade Response in Advanced Urothelial Cancer treatment 1 / 2 active_not_recruiting NCT01215136
First-line Everolimus +/- Paclitaxel for Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma treatment 2 terminated NCT02475213
Safety Study of Enoblituzumab (MGA271) in Combination With Pembrolizumab or MGA012 in Refractory Cancer treatment 1 completed NCT06120413
18F-LN1 PET/CT in Urothelial Carcinomas No drug interventions Not Available Not Available recruiting NCT03039413
Copper Cu-64 TP3805 PET/CT in Imaging Patients With Urothelial Cancer Undergoing Surgery or Biopsy diagnostic 0 completed NCT04045613
Derazantinib and Atezolizumab in Patients With Urothelial Cancer treatment 1 / 2 completed NCT03557918
Trial of Tremelimumab in Patients With Previously Treated Metastatic Urothelial Cancer treatment 2 completed NCT04730219
Perioperative Tislelizumab Combined With Nab-Paclitaxel for Muscle-invasive Urothelial Bladder Carcinoma treatment 2 active_not_recruiting NCT01234519
A Phase I/II Trial of AEZS-108 in Urothelial Cancer Patients Who Failed Platinum-chemotherapy treatment 1 / 2 terminated NCT03980041
Study to Evaluate the Efficacy/Safety of IPI-549 in Combination With Nivolumab in Patients With Advanced Urothelial Carcinoma (MARIO-275) treatment 2 completed NCT06193941
Research on the Accurate Diagnosis of Urinary Tract Tumors and the Development of Kits No drug interventions Not Available Not Available completed NCT05226117
Sacituzumab Govitecan, Preceding Radical Cystectomy, in Treating Patients With Muscle-invasive Bladder Cancer treatment 2 unknown_status NCT03272217
Atezolizumab With Bevacizumab in Previously Untreated Metastatic/Unresectable Urothelial Cancer treatment 2 terminated NCT02589717
An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy Not Available Not Available approved_for_marketing NCT06582017
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma treatment 1 recruiting NCT05239624
Enfortumab Vedotin and Pembrolizumab in People With Bladder Cancer treatment 2 recruiting NCT05321316
Nectin-4 Specific LMW PET Probe Imaging in Urothelial Carcinoma diagnostic Not Available recruiting NCT06262516
Nephroureterectomy With and Without Lymph Node Dissection for Upper Tract Urothelial Cell Carcinoma No drug interventions treatment Not Available recruiting NCT02994758
Development of Diagnostics and Treatment of Urological Cancers No drug interventions treatment Not Available recruiting NCT06111235
A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT treatment 3 recruiting NCT04223063
Exercise-based Pre-habilitation in Bladder Cancer Patients Prior to Radical Cystectomy: a Feasibility Study No drug interventions supportive_care Not Available unknown_status NCT06564363
The Efficacy of the IUrisure for Detection of Recurrent Urothelial Carcinoma No drug interventions Not Available Not Available recruiting NCT02665039
A Trial With Vinflunine in Patients With Metastatic Bladder Cancer and Impaired Renal Function treatment 2 completed NCT05070039
Value of Cortactin Expression in Invasive and Non-invasive Urinary Bladder Urothelial Carcinoma in Egyptian Population No drug interventions basic_science Not Available completed NCT03093922
A Study of Two Dosing Schedules of Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment for Metastatic Bladder Cancer treatment 2 active_not_recruiting NCT05242822
A Study to Evaluate KIN-3248 in Participants With Advanced Tumors Harboring FGFR2 and//or FGFR3 Gene Alterations treatment 1 active_not_recruiting NCT05562830
A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A) treatment 1 / 2 active_not_recruiting NCT05522257
PSMA Expression and PSMA PET Imaging in Soft Tissue Sarcomas and Urothelial Cell Carcinomas No drug interventions diagnostic Not Available recruiting NCT04140526
Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC treatment 1 / 2 recruiting NCT03507166
A Phase II Study of RC48-ADC in Subjects With HER2 Positive Metastatic or Unresectable Urothelial Cancer No drug interventions treatment 2 completed NCT01093066
Prospective Multicentric Evaluation of a Bladder Preservation Strategy No drug interventions treatment 2 terminated NCT03452774
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry No drug interventions Not Available Not Available recruiting NCT04770974
Urothelial Cancer Tumor Bio-markers and Physical-spectroscopic Characteristic No drug interventions Not Available Not Available unknown_status NCT06221774
Safety and Efficacy of TT-00420 Tablets Combined With Toripalimab Injection in Advanced Urological Tumors treatment 1 / 2 not_yet_recruiting NCT06120374
Adjuvant Radioimmunotherapy Compared With Adjuvant Chemotherapy for UTUC Not Available Not Available recruiting NCT03013920
CLE Characteristics of Upper Urinary Tract Urothelial Carcinoma No drug interventions Not Available Not Available completed NCT04116320
Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors treatment 1 active_not_recruiting NCT03992131
A Study to Evaluate Rucaparib in Combination With Other Anticancer Agents in Participants With a Solid Tumor (SEASTAR) treatment 1 / 2 terminated NCT04887831
Trilaciclib, a CDK 4/6 Inhibitor, in Patients With Advanced/Metastatic Bladder Cancer Receiving Chemotherapy Then Avelumab treatment 2 terminated NCT00565227
Phase I Study of Vorinostat in Combination With Docetaxel in Patients With Advanced and Relapsed Solid Malignancies. treatment 1 terminated NCT05600127
Chemotherapy and Sequential Immunotherapy for Locally Advanced Urothelial Cancer treatment 2 recruiting NCT03407976
Apatinib With Pembrolizumab in Previously Treated Advanced Malignancies treatment 1 terminated NCT03170960
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors treatment 1 / 2 active_not_recruiting NCT04871594
Pre-operative Immunotherapy in Stage II-III Urothelial Cancer treatment 1 active_not_recruiting NCT03397394
Rucaparib in Patients With Locally Advanced or Metastatic Urothelial Carcinoma treatment 2 terminated NCT02585362
Whey Protein Supplement in Combination With Physical Exercise and Nutrition Program No drug interventions supportive_care Not Available completed NCT05043662
UroCAD Assay Combined With Computed Tomography Urography and Urine Cytology for UTUC Diagnosis. No drug interventions Not Available Not Available unknown_status NCT03265080
A Study of ADXS-NEO Expressing Personalized Tumor Antigens treatment 1 terminated NCT03898180
Study of First-line Pembrolizumab (MK-3475) With Lenvatinib (MK-7902/E7080) in Urothelial Carcinoma Cisplatin-ineligible Participants Whose Tumors Express Programmed Cell Death-Ligand 1 and in Participants Ineligible for Platinum-containing Chemotherapy (MK-7902-011/E7080-G000-317/ LEAP-011) treatment 3 completed NCT04566029
Evolution of Proteomic Profiles of Intestinal Microbiota in Patients With Locally Advanced or Metastatic Urothelial Carcinomas No drug interventions Not Available Not Available unknown_status NCT04510129
A Multicenter Cancer Biospecimen Collection Study No drug interventions Not Available Not Available recruiting NCT06026189
Safely Reduce Cystoscopic Evaluations for Hematuria Patients No drug interventions diagnostic Not Available recruiting NCT01366144
Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction treatment 1 active_not_recruiting NCT04341740
Investigating Marrow Infiltrating Lymphocytes in Renal Cell Carcinoma No drug interventions other Not Available terminated NCT04295967
Vasculogenic Mimicry in Urothelial Carcinoma No drug interventions Not Available Not Available unknown_status NCT03228667
QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors treatment 2 active_not_recruiting NCT02788201
Genomic Based Assignment of Therapy in Advanced Urothelial Carcinoma No drug interventions treatment 2 completed NCT03076372
A Study Evaluating MM-310 in Patients With Solid Tumors No drug interventions treatment 1 unknown_status NCT04187872
LITT and Pembrolizumab in Recurrent Brain Metastasis treatment 1 terminated NCT05052372
Biomarker Research Study for Patients With FGFR-Mutant Bladder Cancer Receiving Erdafitinib Not Available Not Available terminated NCT03788746
Prevalence of PD-L1 Expression in Patients With Advanced Urothelial Carcinoma No drug interventions Not Available Not Available completed NCT03917381
GEN1046 Safety Trial in Patients With Malignant Solid Tumors treatment 1 / 2 active_not_recruiting NCT03758781
IRX-2 Regimen Combined With Nivolumab in Recurrent/Metastatic Solid Tumors treatment 1 completed NCT02236195
Study of Mocetinostat in Patients With Urothelial Carcinoma Having Inactivating Alterations of Specific Genes treatment 2 completed NCT03639714
A Study of a Personalized Neoantigen Cancer Vaccine treatment 1 / 2 completed NCT05229614
Immunotherapy and Carbon Ion Radiotherapy In Solid Cancers With Stable Disease treatment 2 recruiting NCT02535650
Study of Tipifarnib in Patients With Previously-Treated, Advanced, HRAS Mutant Urothelial Carcinoma treatment 2 unknown_status NCT01360723
DNA Methylation and Arsenic-associated Urothelial Carcinoma No drug interventions Not Available Not Available unknown_status NCT03737123
Trial of Atezolizumab Plus Chemotherapy After Progression on PD-1 or PD-L1 in Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma treatment 2 terminated NCT01907308
Trebananib (AMG 386) in Combination With Docetaxel for Advanced Urothelial Carcinoma treatment 2 withdrawn NCT06339138
Identification of Novel High Quality Methylated DNA Markers in Renal Tumors: Whole Methylome Discovery, Tissue Validation, and Feasibility Testing In Blood and Urine, The INQUIRE Study No drug interventions Not Available Not Available recruiting NCT05290038
ARON-2 Study-Multicentric International Retrospective Study No drug interventions Not Available Not Available recruiting NCT02643043
UC-GENOME: Urothelial Cancer-GENOmic Analysis to iMprove Patient Outcomes and rEsearch No drug interventions other Not Available completed NCT03399643
A Study to Investigate The Effectiveness Of Atezolizumab In Patients With Inoperable Locally-Advanced Or Metastatic Urothelial Carcinoma Of The Urinary Tract (Announce) Not Available Not Available terminated NCT04113603
Diagnostic Values of Urothelial Carcinomas: Single-bolus Versus Split-bolus Computed Tomography Urography No drug interventions other Not Available active_not_recruiting NCT05923190
Enfortumab Vedotin Schedule De-escalation in Metastatic Urothelial Carcinoma treatment 2 recruiting NCT02989064
MAGE-A10ᶜ⁷⁹⁶T for Urothelial Cancer, Melanoma or Head and Neck Cancers No drug interventions treatment 1 completed NCT04146064
Breathomics as Predictive Biomarker for Checkpoint Inhibitor Response No drug interventions Not Available Not Available recruiting NCT05874921
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto Not Available Not Available recruiting NCT04623502
An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy No drug interventions basic_science Not Available recruiting NCT04073602
A Study of RC48-ADC in Subjects With HER2-negative Locally Advanced or Metastatic Urothelial Cancer No drug interventions treatment 2 completed NCT03945084
Maintenance With Niraparib In Patients With Advanced Urothelial Cancer After 1st-line Platinum-based Chemotherapy treatment 2 completed NCT05302284
A Study of RC48-ADC Combined With Toripalimab For First-line Treatment of Urothelial Carcinoma treatment 3 recruiting NCT04596033
TiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell Therapy treatment 1 terminated NCT04579133
Neoadjuvant Durvalumab Alone Versus Durvalumab With Olaparib in Patients Ineligible for Cisplatin With Muscle-Invasive Urothelial Carcinoma of the Bladder Followed by Radical Cystectomy treatment 2 terminated NCT04773951
A Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetics of JS004 in Advanced Solid Tumors treatment 1 unknown_status NCT03475953
A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors treatment 1 / 2 recruiting NCT03967977
Study of Tislelizumab in Combination With Chemotherapy Compared to Chemotherapy Alone for Participants With Urothelial Carcinoma treatment 3 recruiting NCT05431777
A Study to Learn About the Study Medicine (Avelumab) in Japanese Patients With Urothelial Carcinoma That Has Spread Not Available Not Available completed NCT05768347
Intravesical Adoptive Cell Therapy w/ TIL for BCG Exposed High Grade NMIBC No drug interventions treatment 1 recruiting NCT05524545
A Study of Evorpacept (ALX148) With Enfortumab Vedotin for Subjects With Urothelial Carcinoma (ASPEN-07) treatment 1 recruiting NCT04314245
Diagnostic Evaluation of Urine DNA Methylation/Somatic Mutation Profiling for the Detection of Urothelial Carcinoma No drug interventions Not Available Not Available completed NCT03752398
A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3) treatment 1 completed NCT06293898
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors treatment 1 recruiting NCT03915405
KHK2455 (IDO Inhibitor) Plus Avelumab in Adult Subjects With Advanced Bladder Cancer treatment 1 terminated NCT06285097
A Study of PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid Tumors treatment 1 recruiting NCT04994197
Urothelial Tumor Risk Genes Detection With Genetron Uro V1 and LC-WGS No drug interventions Not Available Not Available recruiting NCT05176483
Study of XL092 in Combination With Immuno-Oncology Agents in Subjects With Solid Tumors treatment 1 recruiting NCT01261728
Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy in Patients With High-Grade Upper Tract Urothelial Carcinoma treatment 2 active_not_recruiting NCT03794128
A Study of Personalized Neoantigen Cancer Vaccines No drug interventions Not Available Not Available completed NCT03291028
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma No drug interventions Not Available Not Available recruiting NCT05494411
Named Patient Program for Mitomycin for Pyelocalyceal Solution Not Available Not Available available NCT03232593
A Study of Atezolizumab (Tecentriq®) in Ministry of Food and Drug Safety (MFDS)-Approved Indication(s) Not Available Not Available completed NCT04047693
Neoadjuvant Dose Dense MVAC in MIBC and Locally Advanced Urothelial Carcinoma No drug interventions treatment 2 unknown_status NCT06427993
Urine DNA Methylation Detection for Hematuria Evaluation No drug interventions Not Available Not Available not_yet_recruiting NCT03998371
Application of UCAD for Diagnosing Urothelial Carcinoma. No drug interventions Not Available Not Available unknown_status NCT02278978
BIBF1120 in Patients With Advanced FGFR3 Mutated,Overexpressed,or Wild Type Urothelial Carcinoma treatment 2 unknown_status NCT03548688
Investigation and Detection of Urological Neoplasia in Patients Referred With Suspected Urinary Tract Cancer: No drug interventions Not Available Not Available completed NCT03517488
A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors treatment 1 completed NCT05200988
Checkpoint Inhibition and Chemoradiotherapy as Bladder Sparing Treatment in UC treatment 2 active_not_recruiting NCT03782207
A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice Not Available Not Available active_not_recruiting NCT03988309
STRATA: Safe Testing of Risk for AsymptomaTic MicrohematuriA No drug interventions diagnostic Not Available active_not_recruiting NCT05965856
A Study of SI-B003 and BL-B01D1+SI-B003 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma and Other Solid Tumors No drug interventions treatment 2 recruiting NCT04960956
Glycosylation of Exosomes in Prostate and Urothelial Carcinoma No drug interventions Not Available Not Available terminated NCT02717156
Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab in Solid Tumors treatment 2 recruiting NCT05646485
Bladder Cancer Screening Trial No drug interventions screening Not Available recruiting NCT06265285
Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program health_services_research 2 recruiting NCT03827837
Famitinib Plus Anti-PD1 Therapy for Advanced Urinary System Tumor, Advanced Gynecological Tumors treatment 2 unknown_status NCT03577132
The Efficacy of Neoadjuvant Atezolizumab Treatment in Patients With Advanced Urothelial Bladder Cancer treatment Not Available unknown_status NCT03029832
A Study of MOXR0916 in Combination With Atezolizumab Versus Atezolizumab Alone in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma Who Are Ineligible for Cisplatin-Based Therapy treatment 2 terminated NCT02968732
Cystoscopic Evaluation Predicting pT0 Urothelial Carcinoma of the Bladder No drug interventions diagnostic Not Available active_not_recruiting NCT01378052
DNA Methylation and Urothelial Carcinoma No drug interventions Not Available Not Available unknown_status NCT03584659
Patient-reported Outcomes in Bladder Cancer No drug interventions supportive_care Not Available completed NCT02700659
The Cxbladder Monitoring Study No drug interventions Not Available Not Available completed NCT03582475
Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate treatment 1 completed NCT03209206
The Effectiveness and Safety of Intravesical Docetaxel Instillation for Prevent Bladder Recurrence prevention 2 unknown_status NCT04892849
Clinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and Radiotherapy No drug interventions Not Available Not Available recruiting NCT04264936
A Study of RC48-ADC(Antibody Drug Conjugate) and JS001 to Evaluate the Safety and Pharmacokinetics of Subjects With Locally Advanced or Metastatic Urothelial Cancer treatment 1 / 2 unknown_status NCT02807636
Study of Atezolizumab as Monotherapy and in Combination With Platinum-Based Chemotherapy in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma treatment 3 completed NCT03829436
TPST-1120 as Monotherapy and in Combination With Nivolumab in Subjects With Advanced Cancers treatment 1 completed NCT03809013
A Open-label, Single-arm, Multicenter, Phase II Study of RC48-ADC to Evaluate the Efficacy and Safety of Subjects With HER2 Overexpressing Locally Advanced or Metastatic Urothelial Cancer No drug interventions treatment 2 completed NCT03575013
A Combination of Avelumab and Taxane (AVETAX) for Urothelial Cancer treatment 1 active_not_recruiting NCT00362713
Study of Neoadjuvant Ipilimumab in Patients With Urothelial Carcinoma Undergoing Surgical Resection treatment 1 completed NCT03894618
SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas No drug interventions treatment 1 completed NCT05683418
A Study to Evaluate the Safety and Tolerability of TOS-358 in Adults With Select Solid Tumors No drug interventions treatment 1 recruiting NCT05335941
A Phase 2 Study to Evaluate the Triplet Combination of Pemetrexed Plus AB928 (Etrumadenant) + AB122 (Zimberelimab) in Patients With Previously Treated Advanced or Metastatic MTAP Deficient Urothelial Carcinoma treatment 2 recruiting NCT05585034
Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors treatment 1 recruiting NCT03311334
A Study of DSP-7888 Dosing Emulsion in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced Solid Tumors treatment 1 / 2 terminated NCT05893316
UroCAD for Hematuria Evaluation--A Prospective, Multi-center Study No drug interventions Not Available Not Available not_yet_recruiting NCT03240016
Abraxane With Anti-PD1/PDL1 in Patients With Advanced Urothelial Cancer treatment 2 completed NCT05564416
Testing Anti-Cancer Drugs Erdafitinib With or Without Atezolizumab in Patients With Localized Bladder Cancer Not Able to Receive Cisplatin Chemotherapy, NERA Trial treatment 2 withdrawn NCT06551896
Pemigatinib and Immune Checkpoint Inhibitor Treated FGFR1/2/3 Alteration Advanced Solid Tumor treatment 2 not_yet_recruiting NCT05548296
A Study of ACR-368 in Ovarian Carcinoma, Endometrial Adenocarcinoma, and Urothelial Carcinoma treatment 1 / 2 recruiting NCT06116396
Liquid Biospy for Urinary Cancers No drug interventions Not Available Not Available recruiting NCT03317158
Modern Immunotherapy in BCG-Unresponsive, BCG-Relapsing and High Risk BCG-Naive Non-Muscle Invasive Urothelial Carcinoma of the Bladder treatment 1 / 2 recruiting NCT05699135
A Study to Learn About the Effect of Avelumab First-Line Maintenance in Canadian People With Advanced Bladder Cancer Not Available Not Available terminated NCT04200963
A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma treatment 1 completed NCT03330886
A Study of the Safety of Atezolizumab in Patients With Advanced or Metastatic Urothelial Carcinoma in Argentina Not Available Not Available completed NCT01600339
A Trial of Cabazitaxel for Advanced Transitional Cell Carcinoma (TCC) treatment 2 completed NCT04553939
Neoadjuvant Toripalimab in Combination With Gemcitabine Therapy in Cisplatin Ineligible Local Advanved Bladder Cancer treatment 2 unknown_status NCT01353222
DN24-02 as Adjuvant Therapy in Subjects With High Risk HER2+ Urothelial Carcinoma treatment 2 terminated NCT06405425
A Study of BL-B01D1 + PD-1 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma No drug interventions treatment 2 recruiting NCT02426125
A Study of Ramucirumab (LY3009806) Plus Docetaxel in Participants With Urothelial Cancer treatment 3 completed NCT02887248
Nab-paclitaxel Plus Gemcitabine as First-line Therapy for Cisplatin-ineligible or Cisplatin-incurable Advanced Urothelial Carcinoma treatment 2 terminated NCT04718948
Multimodal Spectroscopy to Detect Urothelial Cancer in Urine No drug interventions Not Available Not Available unknown_status NCT06022757
Study of XNW5004 Tablet in Combination With KEYTRUDA® (Pembrolizumab) in Subjects With Advanced Solid Tumors Who Failed Standard Treatments (KEYNOTE F19) treatment 1 / 2 recruiting NCT02365766
Neoadjuvant Pembrolizumab in Combination With Gemcitabine Therapy in Cis-eligible/Ineligible UC Subjects treatment 1 / 2 active_not_recruiting NCT04198766
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist) treatment 1 / 2 recruiting NCT05086666
A Phase 1b/2 Clinical Study to Evaluate the Safety and Tolerability and Efficacy of AZD4547 treatment 1 / 2 unknown_status NCT01993966
EGCG Modulate the Cytotoxic Effects of Chemotherapeutic Agents in Human Urothelial Carcinoma Cells No drug interventions Not Available Not Available unknown_status NCT03924466
Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients No drug interventions diagnostic 2 recruiting NCT00588666
Phase II Trial of Gemcitabine, Carboplatin, and Bevacizumab in Chemotherapy Naive Patients With Advanced/Metastatic Urothelial Carcinoma treatment 2 completed NCT05868265
A Study of Enfortumab Vedotin in People With Urothelial Carcinoma of the Upper Urinary Tract treatment 2 recruiting NCT05046665
Phase I Study to Evaluate the Diagnostic Performance of 89Zirconium Girentuximab PET in Urothelial Cancer Patients diagnostic 1 completed NCT01328574
TRC105 in Adults With Advanced/Metastatic Urothelial Carcinoma treatment 2 completed NCT03190174
Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers treatment 1 / 2 completed NCT03606174
A Phase 2 Study of Sitravatinib in Combination With PD-(L)1 Checkpoint Inhibitor Regimens in Patients With Advanced or Metastatic Urothelial Carcinoma treatment 2 terminated NCT05775874
A Study to Evaluate the Safety and Efficacy of AZD4547 Combination With Tislelizumab in Patients With mUC treatment 2 recruiting NCT04688931
A Phase 3 Study of UGN-102 for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer treatment 3 terminated NCT03520231
Study Comparing Denosumab With Standard Treatment in Urothelial Cancer Patients With Bone Metastases treatment 2 completed NCT04459273
Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers basic_science 1 recruiting NCT05107427
Study of MRx0518 and Avelumab in Patients With Urothelial Carcinoma treatment 2 withdrawn NCT04802876
Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients With PD1-high mRNA Expressing Tumors treatment 2 recruiting NCT03013894
Confocal Laser Endomicroscopy in the Lower Urinary Tract No drug interventions Not Available Not Available completed NCT05902494
HER2 and LA/mUC: A Multi-country Chart Review Cohort Study No drug interventions Not Available Not Available recruiting NCT01524991
First-Line Gemcitabine, Cisplatin + Ipilimumab for Metastatic Urothelial Carcinoma treatment 2 completed NCT05723991
Study of Disitamab Vedotin Combined With Gemcitabine in Neoadjuvant Treatment of Urothelial Carcinoma treatment 4 recruiting NCT03511391
CHEckpoint Inhibition in Combination With an Immunoboost of External Beam Radiotherapy in Solid Tumors treatment 2 completed NCT06040762
A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and Upper Tract Urothelial Cancer, Get Moving Trial No drug interventions supportive_care Not Available recruiting NCT04678362
TALazoparib and Avelumab as Maintenance Therapy in Platinum-Sensitive Metastatic or Locally Advanced URothelial Carcinoma treatment 2 recruiting NCT05137262
A Phase II Multicenter Study of Chemotherapy Versus Chemotherapy Plus Durvalumab (MEDI 4736) in Patients With Lymph Node Positive Urothelial Carcinoma of the Bladder treatment 2 recruiting NCT04943380
Efficacy and Utility of Cxbladder Tests in Hematuria Patients No drug interventions Not Available Not Available active_not_recruiting NCT03735680
A Study to Evaluate ONM-100, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer diagnostic 2 completed NCT04628780
Study to Test the Safety and Tolerability of PF-07209960 in Advanced or Metastatic Solid Tumors No drug interventions treatment 1 terminated NCT06469229
Performance Evaluation of Urine DNA Methylation Testing for the Detection of Urothelial Carcinoma in Patients With Hematuria No drug interventions Not Available Not Available not_yet_recruiting NCT04197089
Biological Effect of Vitamin D in Patients With Urothelial Carcinoma treatment 4 completed NCT05337189
A Multicenter Clinical Trial of Urine DNA Testing for Bladder Cancer in China No drug interventions Not Available Not Available recruiting NCT05496192
A Study of Nivolumab Intravenous (IV) to Subcutaneous (SC) Switch in Adjuvant Melanoma and Bladder Cancer treatment 2 withdrawn NCT03689192
Arginase-1 Peptide Vaccine in Patients With Metastatic Solid Tumors No drug interventions treatment 1 completed NCT03677544
Predictive Factorsfor Final Pathologic Ureteral Sections No drug interventions Not Available Not Available completed NCT04586244
An Umbrella Study to Determine the Safety and Efficacy of Various Monotherapy or Combination Therapies in Neoadjuvant Urothelial Carcinoma treatment 2 terminated NCT06443944
An Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCG Not Available Not Available available NCT06321640
Study for the Multidimensional Analyses of Resistance and Toxicity to Immune- and Targeted-therapies. No drug interventions Not Available Not Available recruiting NCT02986867
SAbR Induced Innate Immunity in Urothelial Carcinoma, Melanoma, and Cervical Carcinoma No drug interventions basic_science Not Available completed NCT06113367
Immunotherapy in Upper Tract Urothelial Carcinoma No drug interventions Not Available Not Available not_yet_recruiting NCT03374267
Registry Platform Urologic Cancer No drug interventions Not Available Not Available recruiting NCT04106167
Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy No drug interventions Not Available Not Available terminated NCT06178601
A Study of RC48-ADC Combined With Cadonilimab（AK104）in the Treatment of HER2-expression Locally Advanced or Metastatic Urothelial Carcinoma treatment 2 recruiting NCT03212404
Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers treatment 1 recruiting NCT03658304
Trial of Mitomycin C During Nephroureterectomy for Urothelial Carcinoma treatment 2 completed NCT06169904
B7-Family Score in Urothelial Carcinoma Not Available Not Available completed NCT05574504
Phase II Trial of Lurbinectedin Combined With Avelumab as Switch Maintenance Firstline Therapy treatment 2 withdrawn NCT04970472
Bio Clinical Collection of Urothelial Carcinoma No drug interventions Not Available Not Available recruiting NCT04902872
Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors No drug interventions treatment 1 / 2 active_not_recruiting NCT03523572
Trastuzumab Deruxtecan With Nivolumab in Advanced Breast and Urothelial Cancer treatment 1 unknown_status NCT02482168
Study of the CD40 Agonistic Monoclonal Antibody APX005M treatment 1 completed NCT03849469
A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors treatment 1 completed NCT03676946
A Clinical Study of PD-L1 Antibody ZKAB001（Drug Code） in Locally Advanced and Metastatic Urothelial Carcinoma treatment 1 / 2 unknown_status NCT05823246
Safety and Efficacy Study of QLF31907 in Advanced Melanoma and Urothelial Carcinoma No drug interventions treatment 2 recruiting NCT02232646
A Study of BBI503 in Adult Patients With Advanced Urologic Malignancies treatment 2 withdrawn NCT04211012
A Study on Toripalimab Plus Nab-Paclitaxel With or Without Cisplatin as First-line Treatment of Urothelial Carcinoma treatment 2 unknown_status NCT03208712
Radium-223 and Atezolizumab in Patients With Urothelial Carcinoma With Bone Metastases Who Have Had Disease Progression After Platinum-Based Chemotherapy treatment 0 terminated NCT03633110
Safety, Tolerability, Immunogenicity, and Antitumor Activity of GEN-009 Adjuvanted Vaccine treatment 1 / 2 completed NCT03841110
FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors treatment 1 completed NCT04066595
Cabozantinib in Patients With Locally Advanced or Metastatic Urothelial Cell Carcinoma. treatment 2 terminated NCT01042795
Trial of Adjuvant Sutent for Patients With High Risk Urothelial Carcinoma After Neoadjuvant Chemotherapy and Cystectomy treatment 2 terminated NCT04344795
Phase 1a/1b Study of TPST-1495 as a Single Agent and in Combination With Pembrolizumab in Subjects With Solid Tumors treatment 1 active_not_recruiting NCT05889195
Detection and Risk Stratification in Veterans Presenting With Microscopic Hematuria No drug interventions Not Available Not Available recruiting NCT03517995
Randomized, Phase II Clinical Trial of Sulforaphane in Bladder Cancer Chemoprevention prevention 2 withdrawn NCT04452214
A Study of the Safety and Tolerance of CAN04 and Pembrolizumab in Combination With and Without Carboplatin and Pemetrexed in Subjects With Solid Tumors treatment 1 completed NCT06356155
Study of Neoadjuvant Enfortumab Vedotin and Pembrolizumab in Cisplatin-eligible Upper Tract Urothelial Cancer treatment 2 not_yet_recruiting NCT03287050
Anti-PD(L)1 and SBRT in the Treatment of Advanced, Platinum-Refractory Urothelial Carcinoma treatment 2 terminated NCT05243550
A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer treatment 3 active_not_recruiting NCT02845323
Neoadjuvant Nivolumab With and Without Urelumab in Cisplatin-Ineligible or Chemotherapy-refusing Patients With Muscle-Invasive Urothelial Carcinoma of the Bladder treatment 2 active_not_recruiting NCT05945108
Brazilian Reality of Urinary Bladder Cancers - BRA-BLADDER No drug interventions Not Available Not Available completed NCT04173338
Cabozantinib With Pemetrexed in Advanced Non-small Cell Lung Cancer, Urothelial Cancer and Malignant Mesothelioma treatment 1 terminated NCT04383938
Phase 1/2 Study of APR-246 in Combination With Pembrolizumab in Subjects With Solid Tumor Malignancies treatment 1 / 2 completed NCT05018442
89Zr-girentuximab PET in Urothelial Cancer Patients diagnostic 1 / 2 recruiting NCT03133390
Atezolizumab With or Without Bevacizumab in Cisplatin-ineligible Patients treatment 2 active_not_recruiting NCT01225848
Trial of Maintenance SU011248 Versus Placebo Post Chemotherapy Patients With Advanced Urothelial Carcinoma treatment 2 completed NCT02978118
Exploring Relevant Immune-based Biomarkers and Circulating Tumor Cells During Treatment With Immunotherapy in Genitourinary Malignancies (CTC Immune Based Biomarkers) No drug interventions Not Available Not Available recruiting NCT06235268
Prospective and Multicenter Italian Registry of Locally Advanced-Metastatic Urothelial Carcinoma No drug interventions Not Available Not Available recruiting